Outsourced Pharma Products & Services
-
Ion Exchangers: Capto™ S, Capto Q, & Capto DEAE
10/17/2011
Capto S, Capto Q and Capto DEAE are, respectively, strong cation, strong anion and weak anion exchange media for packed bed chromatography that increase speed and throughput in capture and intermediate purification.
-
Document Control Software For Life Sciences
8/23/2021
Digital document control systems introduce automation into your processes. A digital solution is not only more efficient, it also makes it easier to keep up on regulatory changes and maintain compliance.
-
Packaging QP Services
8/3/2020
Our Packaging QP Services delivers a vital role in bringing new products to market. Our highly experienced team ensures that commercial products are launched in accordance with global regulatory requirements with ongoing batch release for commercially established products.
-
RNA, Cell, Protein, And Vector Engineering
8/4/2023
We have centralized RNA, cell, protein, and vector engineering to improve productivity and scalability and to ensure external partners and internal programs have access to the necessary tools to build novel therapies.
-
High Performance, Reliable, And Flexible Bioreactors
7/17/2023
High performance, reliability, and flexibility define this next-generation single-use system.
-
Your Partner For Chemocatalysis Solutions
6/20/2025
Chemocatalyzed steps in synthetic routes are known to afford high selectivities, yields and atom economy. A chemocatalytic reaction optimization requires large number of experiments to identify a suitable catalyst, catalyst loading, solvent, temperature, pressure etc. The chemocatalysis team at Aragen Life Sciences has the capabilities to optimize processes using high throughput screening combined with DoE from gram to multikilo scale with ready access to catalysts and ligands.
-
Analytical Laboratory Services
4/6/2016
PCI offers in-house laboratories providing a range of analytical services to support clients in the development, clinical and commercial supply of medicines globally.
-
Cell Therapy Services: Process Development And cGMP Manufacturing
5/28/2025
Now that you have the best donated cellular material, it is time to optimize your cell therapy process for cGMP manufacturing. We offer R&D services including process development and cGMP production for Phase I through Commercial manufacturing.
-
Scale Your Vaccine With Path-To-PAD
3/1/2024
The COVID-19 pandemic highlighted the urgent need for a quick, efficient, and scalable vaccine production process. Resilience's Vaccine Path-To-PAD (Process and Analytical Development) program provides a clear and easy path to maximize yields at the beginning of development, with deep expertise in vaccines, robust expression platforms, and high-quality Vero and Quail cell lines.
-
Expanding Cell & Gene Therapy Global Supply Chain Offerings
7/26/2023
As cell and gene therapies continue to transform modern medicine, Cryoport Systems evolves its products and solutions to meet the needs of the industry and the patients it serves.